Neuraminidase
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
*[[Neuraminidase Inhibitor Pharmacokinetics]]<br /> | *[[Neuraminidase Inhibitor Pharmacokinetics]]<br /> | ||
*[[Carbohydrate binding domain from Streptococcus pneumoniae NanA sialidase complexed with 3'-sialyllactose]]<br /> | *[[Carbohydrate binding domain from Streptococcus pneumoniae NanA sialidase complexed with 3'-sialyllactose]]<br /> | ||
| - | *[[Neuraminidase Inhibitor Pharmacokinetics References]]<br />. | + | *[[Treatments:Neuraminidase Inhibitor Pharmacokinetics References]]<br />. |
==3D structures of Neuraminidase== | ==3D structures of Neuraminidase== | ||
Revision as of 07:58, 28 February 2016
Neuraminidase (NAN) cleaves the glycosidic bonds of neuraminic acid. The viral NAN is a drug target for prevention of influenza.
See also
- Avian Influenza Neuraminidase, Tamiflu and Relenza
- Molecular Playground/Relenza
- Molecular Playground/Tamiflu
- Oseltamivir (Tamiflu)
- Treatments:Influenza
- User:Michael Strong/H1N1/NA for Influenza virus neuraminidase
- User:Michael Strong/H1N1/NA/MSA for multiple sequence alignment.
For other inhibitors see
- Neuraminidase Inhibitor Pharmacokinetics
- Carbohydrate binding domain from Streptococcus pneumoniae NanA sialidase complexed with 3'-sialyllactose
- Treatments:Neuraminidase Inhibitor Pharmacokinetics References
.
3D structures of Neuraminidase
Updated on 28-February-2016
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Eran Hodis
